English
Bulgarian
Chinese (Simplified)
Croatian
Czech
Danish
Dutch
Finnish
French
German
Greek
Hebrew
Hindi
Indonesian
Italian
Japanese
Korean
Macedonian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swedish
Thai
Turkish
Vietnamese
News
iCMLf Conversation on CML and COVID-19 in Russian - Join Dr. Elza Lomaia on September 29th at 14.00 Moscow Time
September 2020 - Please join us for an iCMLf Conversation on COVID-19 and CML in Russian. On September 29th Dr Elza Lomaia and her collagues from the Russian Federation will be sharing their experience with CML management during the pandemic.
CML management during the COVID-19 pandemic
– perspectives from Russia (in Russian)
September 29th at 14.00 Moscau Time / 13.00 Central European Time
- Dr Elza Lomaia, Almazov National Medical Research Centre, Saint-Petersburg (Russian Federation)
- Dr Jurii Osipov, Almazov National Medical Research Centre, Saint-Petersburg (Russian Federation)
- Dr Ekaterina Chelysheva, National Research Centre for Hematology, Moscow (Russian Federation)
iCMLf Conversation on CML and COVID-19 in Portuguese - Join Dr Katia Pagnano on Sept 11th at 8.00 Brazilian Time
Bem-vinda - Please join us for the first non-English iCMLf Conversation on COVID-19 and CML in Portuguese. On September 11th Dr Katia Pagnano and her colleagues from Brazil will be sharing their experience with CML management during the pandemic and local perspectives.
CML management during the COVID-19 pandemic – perspectives from Brazil (in Portuguese)
September 11th at 8.00 Brazilian Time (BRT)
- Dr Katia Pagnano, Universidade de Campinas, São Paulo (Brazil)
- Dr Ana Carolina Torelli, Hospital Brigadeiro, São Paulo-SP (Brazil)
- Dr Carla Boquimpani, Instituto Estadual de Hematologica Arthur de Sigueira Cavalcanti, Rio de Janeiro (Brazil)
World CML Day 9/22 - Join us for expert conversations from the USA, UK and China
September 2020 'Today, together, more than ever’ – We have taken this year’s World CML Day motto to heart and are happy to host two important expert live discussions on World CML Day on September 22nd to bring the CML community even closer together through our online activities during these difficult times.
On September 22nd at 14.00 CET, Dr Ehab Atallah and Professor Mhairi Copland will be discussing current CML research and the impact of COVID-19 both from a US and a European perspective. At 17.00 central China time we will be hosting an iCMLf conversation on CML and COVID-19 in Mandarin.
Please join us for iCMLf conversations on COVID-19 and CML in non-english languages
September 2020 - We are happy to host a series of iCMLf Conversations on COVID-19 and CML in different languages including French, Mandarin, Portuguese, Russian and Spanish over the next couple of weeks.
Join Professor Hochhaus discussing 2020 ELN recommendations - August 28th at 14.00 CET
August 2020 - Please join us for our next iCMLf Conversation on CML. On August 28, Professor Andreas Hochhaus will be discussing the recent update to the European LeukemiaNet recommendations for treating chronic myeloid leukemia.
European LeukemiaNet (ELN) 2020 recommendations for treating chronic myeloid leukemia
Professor Andreas Hochhaus, University of Jena (Germany)
Date: August 28th at 14.00 Central European Time (CET)
Run.Ride.Cure - The John Goldman Fun Run is going virtual!
August 2020 - Run. Ride. Cure
Last year we climbed Kilimanjaro this year we are going virtual.
Together we Cure CML
Each year during the John Goldman meeting on CML, participants come to together for a 5k run to celebrate the CML community and raise funds for the work of the iCMLf. The 2020 meeting has gone virtual and so is the run. With a difference!
This year you choose how, when and who! Choose your activity, set your goal and invite friends and family to support you. You can even form a team!
Register for $20 and during September and until October the 4th your photos completing your challenge can be posted on the Community wall at the virtual John Goldman meeting.
Join us, celebrate the CML community and help the iCMLf Move Towards a Cure
